speb/financial-data huggingface dataset:
DuPont ROE decomposition for CEIR.L (annual period ending 2022-12-31)
ROE: 6.703977337135562%
Net margin: 0.7958592602702801%
Asset turnover: 2.366665395546224
Equity multiplier (leverage): 3.5592574507763897
EBIT margin: 0.8589827243833488%
Interest burden factor: 1.1632642900306833
Tax burden factor: 0.7964773832469394
ROE archetype: Standard Business
DuPont ROE decomposition for CEIR.L (annual period ending 2023-12-31)
ROE: 7.188308526429308%
Net margin: 0.9644592014406029%
Asset turnover: 2.180363883321845
Equity multiplier (leverage): 3.4183290723693514
EBIT margin: 1.2725808237074143%
Interest burden factor: 0.9869447399593168
Tax burden factor: 0.767901736060738
ROE archetype: Standard Business
DuPont ROE decomposition for CEIR.L (annual period ending 2024-12-31)
ROE: 8.03979717962085%
Net margin: 1.2847703541383675%
Asset turnover: 2.009740328405636
Equity multiplier (leverage): 3.1137205918363557
EBIT margin: 1.6305398179045214%
Interest burden factor: 1.0341024595139832
Tax burden factor: 0.761957111810202
ROE archetype: Standard Business
DuPont ROE decomposition for CEIR.L (annual period ending 2025-12-31)
ROE: 5.40374379846713%
Net margin: 1.0429501126865104%
Asset turnover: 1.7460586855415623
Equity multiplier (leverage): 2.9673746237306338
EBIT margin: 1.4041276623320922%
Interest burden factor: 0.9823143059949513
Tax burden factor: 0.756147413698467
ROE archetype: Standard Business
DuPont ROE decomposition for CELL.V (quarterly period ending 2024-12-31)
ROE: -15.462658040933228%
Asset turnover: 0
Equity multiplier (leverage): 1.0154942182449245
ROE archetype: Low Return
DuPont ROE decomposition for CELL.V (quarterly period ending 2025-03-31)
ROE: -26.578314094477882%
Asset turnover: 0
Equity multiplier (leverage): 1.0091963925232263
ROE archetype: Low Return
DuPont ROE decomposition for CELL.V (quarterly period ending 2025-06-30)
ROE: -13.319611073371624%
Asset turnover: 0
Equity multiplier (leverage): 1.008487517856154
ROE archetype: Low Return
DuPont ROE decomposition for CELL.V (quarterly period ending 2025-09-30)
ROE: -7.316524544744099%
Asset turnover: 0
Equity multiplier (leverage): 1.013458747647459
ROE archetype: Low Return
DuPont ROE decomposition for CELL.V (quarterly period ending 2025-12-31)
ROE: -6.403387394162935%
Asset turnover: 0
Equity multiplier (leverage): 1.00835239894736
ROE archetype: Low Return
DuPont ROE decomposition for CENTRUM.NS (annual period ending 2023-03-31)
ROE: -7.984634643121558%
Net margin: -12.339345448290599%
Asset turnover: 0.10339493171625813
Equity multiplier (leverage): 6.25840515843225
EBIT margin: 12.580363316910692%
Interest burden factor: -1.1698102705612257
ROE archetype: Low Return
DuPont ROE decomposition for CENTRUM.NS (annual period ending 2024-03-31)
ROE: -3.902443272565833%
Net margin: -3.4971616753017853%
Asset turnover: 0.13890515644600568
Equity multiplier (leverage): 8.033457868486954
EBIT margin: 25.712666256697897%
Interest burden factor: -0.20386196149998587
ROE archetype: Low Return
DuPont ROE decomposition for CENTRUM.NS (annual period ending 2025-03-31)
ROE: -8.705312053449585%
Net margin: -4.36621503815793%
Asset turnover: 0.1683729417445313
Equity multiplier (leverage): 11.841505545543589
EBIT margin: 35.47465601265899%
Interest burden factor: -0.15612867312210876
ROE archetype: Low Return
DuPont ROE decomposition for CENTRUM.NS (annual period ending 2026-03-31)
ROE: -8.887756397799922%
Net margin: -3.7469589355438933%
Asset turnover: 0.159027503045798
Equity multiplier (leverage): 14.915608277929575
EBIT margin: 25.721803649870917%
Interest burden factor: -0.2667217693612931
ROE archetype: Low Return
DuPont ROE decomposition for CENTUM.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 6.095604238486347
ROE archetype: Standard Business
DuPont ROE decomposition for CENTUM.NS (quarterly period ending 2025-03-31)
ROE: 5.459525953356246%
Net margin: 8.086390070175966%
Asset turnover: 0.21476369281114305
Equity multiplier (leverage): 3.143687621269958
EBIT margin: 15.46951778442304%
Interest burden factor: 0.9340910194764195
Tax burden factor: 0.5596141846921797
ROE archetype: Standard Business
DuPont ROE decomposition for CENTUM.NS (quarterly period ending 2025-06-30)
Net margin: 1.6986394945067458%
EBIT margin: 4.73046052257073%
Interest burden factor: 0.8195748094665063
Tax burden factor: 0.43813625685199686
ROE archetype: Standard Business
DuPont ROE decomposition for CENTUM.NS (quarterly period ending 2025-09-30)
ROE: 1.08296965586086%
Net margin: 1.4743136305190936%
Asset turnover: 0.20592470980273692
Equity multiplier (leverage): 3.567121850083828
EBIT margin: 2.297016178771417%
Interest burden factor: 1.3417779126213594
Tax burden factor: 0.4783493499152063
ROE archetype: Low Return
DuPont ROE decomposition for CENTUM.NS (quarterly period ending 2025-12-31)
Net margin: -19.058700798459252%
EBIT margin: 6.82594699366356%
Interest burden factor: -1.7737836860191718
ROE archetype: Standard Business
DuPont ROE decomposition for CENTUM.NS (quarterly period ending 2026-03-31)
ROE: 0.5044989617780511%
Net margin: 0.48397996795108267%
Asset turnover: 0.2601165875496656
Equity multiplier (leverage): 4.007419826193954
EBIT margin: 12.90013191405224%
Interest burden factor: 1.057099718619175
Tax burden factor: 0.035490921681923436
ROE archetype: Low Return
DuPont ROE decomposition for CEPS.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 4.390052356020942
ROE archetype: Standard Business
DuPont ROE decomposition for CEPS.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 4.569018393168326
ROE archetype: Standard Business
DuPont ROE decomposition for CEPS.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 5.079927804886585
ROE archetype: Standard Business
DuPont ROE decomposition for CEQ.V (quarterly period ending 2024-12-31)
ROE: -563.6363636363642%
Net margin: -84.88560619708161%
Asset turnover: 0.07262759874919862
Equity multiplier (leverage): 91.42464114832545
EBIT margin: 34.750495406233114%
Interest burden factor: -1.7345775012960083
ROE archetype: Low Return
DuPont ROE decomposition for CEQ.V (quarterly period ending 2025-03-31)
ROE: -147.85353535353482%
Net margin: -7.985542825968358%
Asset turnover: 0.1940593797351931
Equity multiplier (leverage): 95.40972222222189
EBIT margin: 11.954446262956901%
Interest burden factor: 0.3268682258984598
Tax burden factor: -2.0436300174520072
ROE archetype: Low Return
DuPont ROE decomposition for CEQ.V (quarterly period ending 2025-06-30)
Net margin: -16.390618788922755%
Asset turnover: 0.10564492884107701
EBIT margin: 0.5167616271366106%
Interest burden factor: -18.871794871794872
ROE archetype: Standard Business
DuPont ROE decomposition for CEQ.V (quarterly period ending 2025-09-30)
Net margin: -54.38241249638415%
Asset turnover: 0.0956114453769434
EBIT margin: -6.551923633207983%
ROE archetype: Standard Business
DuPont ROE decomposition for CEQ.V (quarterly period ending 2025-12-31)
Net margin: -184.39232409381663%
Asset turnover: 0.07187735501124341
EBIT margin: -0.2345415778251599%
ROE archetype: Standard Business
DuPont ROE decomposition for CEQ.V (quarterly period ending 2026-03-31)
Net margin: -33.25343761826669%
Asset turnover: 0.13075875607371068
EBIT margin: 0.8704427904629747%
Interest burden factor: -26
ROE archetype: Standard Business
DuPont ROE decomposition for CETX (quarterly period ending 2025-03-31)
ROE: 128.3892465216277%
Net margin: 31.696857744780427%
Asset turnover: 0.5893587515666515
Equity multiplier (leverage): 6.872784118847037
EBIT margin: 16.942306147509957%
Interest burden factor: 1.8889684770309634
Tax burden factor: 0.9904190270994211
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CETX (quarterly period ending 2025-06-30)
ROE: -85.88885670946111%
Net margin: -26.779597938376455%
Asset turnover: 0.3640778324653048
Equity multiplier (leverage): 8.809241832936845
EBIT margin: -3.7864785438914303%
ROE archetype: Low Return
DuPont ROE decomposition for CETX (quarterly period ending 2025-09-30)
ROE: -50.52978032858226%
Net margin: -17.135841269673392%
Asset turnover: 0.391186031225479
Equity multiplier (leverage): 7.538043534902667
EBIT margin: -6.384331281308239%
ROE archetype: Low Return
DuPont ROE decomposition for CETX (quarterly period ending 2025-12-31)
ROE: -108.7395308004264%
Net margin: -127.41431067683502%
Asset turnover: 0.29843666909994626
Equity multiplier (leverage): 2.859677521568953
EBIT margin: -17.393577796894885%
ROE archetype: Low Return
DuPont ROE decomposition for CETX (quarterly period ending 2026-03-31)
ROE: 2.8434185022203193%
Net margin: 5.022034046481642%
Asset turnover: 0.27560526464789287
Equity multiplier (leverage): 2.0543461530552185
EBIT margin: -12.025872681730016%
Tax burden factor: 0.7000588110898266
ROE archetype: Low Return
DuPont ROE decomposition for CFF.TO (annual period ending 2022-12-31)
ROE: 16.74516450361769%
Net margin: 10.590668440087377%
Asset turnover: 0.8989505296328933
Equity multiplier (leverage): 1.7588558755101105
EBIT margin: 11.87498594696688%
Interest burden factor: 1.237498589005531
Tax burden factor: 0.7206851197429477
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CFF.TO (annual period ending 2023-12-31)
ROE: -23.79219015204109%
Net margin: -21.698106524301778%
Asset turnover: 0.6023528920370822
Equity multiplier (leverage): 1.8203780297664487
EBIT margin: -27.438253763148353%
ROE archetype: Low Return
DuPont ROE decomposition for CFF.TO (annual period ending 2024-12-31)
ROE: -28.23267093721012%
Net margin: -23.314210918564815%
Asset turnover: 0.579145217755802
Equity multiplier (leverage): 2.0909505911826547
EBIT margin: -20.247631096052558%
ROE archetype: Low Return
DuPont ROE decomposition for CFF.TO (annual period ending 2025-12-31)
ROE: -54.04835411739987%
Net margin: -24.985358978238818%
Asset turnover: 0.7084401717835103
Equity multiplier (leverage): 3.0534702996592196
EBIT margin: -26.357061595969444%
ROE archetype: Low Return
DuPont ROE decomposition for CFT.SW (annual period ending 2022-12-31)
ROE: 22.01457122454329%
Net margin: 10.282690062676933%
Asset turnover: 0.8794393260773711
Equity multiplier (leverage): 2.4344317493604746
EBIT margin: 9.939539665483778%
Interest burden factor: 1.2750645130459715
Tax burden factor: 0.8113501403359735
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CFT.SW (annual period ending 2023-12-31)
ROE: 24.35006413163627%
Net margin: 10.286700224453753%
Asset turnover: 0.9989643553569137
Equity multiplier (leverage): 2.3695945013682773
EBIT margin: 10.739679453574718%
Interest burden factor: 1.205630064925833
Tax burden factor: 0.7944575471698113
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CFT.SW (annual period ending 2024-12-31)
ROE: 25.62795712364619%
Net margin: 11.726534284013473%
Asset turnover: 0.8943090892722917
Equity multiplier (leverage): 2.443749390446385
EBIT margin: 11.918052335588316%
Interest burden factor: 1.2247506582621879
Tax burden factor: 0.80337203090594
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CFT.SW (annual period ending 2025-12-31)
ROE: 29.863401901591676%
Net margin: 12.78841121093274%
Asset turnover: 0.970197319594348
Equity multiplier (leverage): 2.406925322624251
EBIT margin: 14.473707795885884%
Interest burden factor: 1.1336156985132484
Tax burden factor: 0.7794189139732671
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CFY.V (quarterly period ending 2024-12-31)
ROE: 2.9711277255571322%
Net margin: 8.607265231077806%
Asset turnover: 0.10692692691201845
Equity multiplier (leverage): 3.2282640575041475
EBIT margin: 22.767222887706495%
Interest burden factor: 0.7358600226361995
Tax burden factor: 0.5137595610242767
ROE archetype: Low Return
DuPont ROE decomposition for CFY.V (quarterly period ending 2025-03-31)
ROE: 0.7931489212094742%
Net margin: 3.147109515602236%
Asset turnover: 0.07967661084769398
Equity multiplier (leverage): 3.1630934967788082
EBIT margin: 4.495462639382196%
Interest burden factor: 1.2751535691590765
Tax burden factor: 0.5490033222591362
ROE archetype: Low Return
DuPont ROE decomposition for CFY.V (quarterly period ending 2025-06-30)
ROE: 0.6460562579825102%
Net margin: 2.684856919373025%
Asset turnover: 0.07737144059885348
Equity multiplier (leverage): 3.11005814137097
EBIT margin: 7.848355867981836%
Interest burden factor: 0.7971783587885063
Tax burden factor: 0.42912810521188505
ROE archetype: Low Return
DuPont ROE decomposition for CFY.V (quarterly period ending 2025-09-30)
ROE: 1.1056689485319826%
Net margin: 5.283483327499181%
Asset turnover: 0.06781328908302191
Equity multiplier (leverage): 3.0859576569687195
EBIT margin: 11.139466344470918%
Interest burden factor: 0.7551951343132286
Tax burden factor: 0.6280536912751677
ROE archetype: Low Return
DuPont ROE decomposition for CFY.V (quarterly period ending 2025-12-31)
ROE: 2.285848983617598%
Net margin: 8.001601321089899%
Asset turnover: 0.09433790790813532
Equity multiplier (leverage): 3.0281988155500206
EBIT margin: 13.357686758242215%
Interest burden factor: 0.6956793206793207
Tax burden factor: 0.8610662358642973
ROE archetype: Low Return
DuPont ROE decomposition for CFY.V (quarterly period ending 2026-03-31)
ROE: 1.6170510829156375%
Net margin: 6.126184797627324%
Asset turnover: 0.08725804859193859
Equity multiplier (leverage): 3.02501930074029
EBIT margin: 10.89265755498253%
Interest burden factor: 0.7234386361800113
Tax burden factor: 0.7774179137815501
ROE archetype: Low Return
DuPont ROE decomposition for CFZ.DE (annual period ending 2022-12-31)
ROE: 18.46056454934101%
Net margin: 34.14596182656575%
Asset turnover: 0.032067022286917116
Equity multiplier (leverage): 16.859589420979283
Tax burden factor: 0.8659189895144783
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CFZ.DE (annual period ending 2023-12-31)
ROE: 17.44970399092458%
Net margin: 30.09114304203993%
Asset turnover: 0.038312233231493506
Equity multiplier (leverage): 15.136027605627637
Tax burden factor: 0.8394099720230834
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CFZ.DE (annual period ending 2024-12-31)
ROE: 15.299785227513729%
Net margin: 28.227900237921027%
Asset turnover: 0.039930422683349905
Equity multiplier (leverage): 13.57384398101913
Tax burden factor: 0.8370253187291926
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CFZ.DE (annual period ending 2025-12-31)
ROE: 15.311279159698305%
Net margin: 29.01504265306159%
Asset turnover: 0.042349533210833706
Equity multiplier (leverage): 12.460619475085297
Tax burden factor: 0.8404241533649
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CGAU (annual period ending 2022-12-31)
ROE: -4.265004908050695%
Net margin: -8.87224196793725%
Asset turnover: 0.3725449065010666
Equity multiplier (leverage): 1.2903500045020386
EBIT margin: 11.892704350913723%
Interest burden factor: -0.429329236477477
ROE archetype: Low Return
DuPont ROE decomposition for CGAU (annual period ending 2023-12-31)
ROE: -4.737461433098318%
Net margin: -7.3717596972134825%
Asset turnover: 0.4848574485119065
Equity multiplier (leverage): 1.3254411386507614
EBIT margin: 3.8981133889433583%
Interest burden factor: 0.31722469112822543
Tax burden factor: -5.961419979463106
ROE archetype: Low Return
DuPont ROE decomposition for CGAU (annual period ending 2024-12-31)
ROE: 4.634089741944846%
Net margin: 6.619497852207858%
Asset turnover: 0.5128853594255052
Equity multiplier (leverage): 1.3649573838956917
EBIT margin: 19.455612707420237%
Interest burden factor: 0.7366276043319833
Tax burden factor: 0.4618831762008997
ROE archetype: Low Return
DuPont ROE decomposition for CGAU (annual period ending 2025-12-31)
ROE: 32.0327002930984%
Net margin: 42.17853732805032%
Asset turnover: 0.539922607645429
Equity multiplier (leverage): 1.406599706902748
EBIT margin: 22.70949224375651%
Interest burden factor: 2.3248830412146537
Tax burden factor: 0.7988826357102404
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CGCL.NS (annual period ending 2023-03-31)
ROE: 5.739894869282165%
Net margin: 15.436637481067578%
Asset turnover: 0.11234066293776145
Equity multiplier (leverage): 3.3098952563283452
EBIT margin: 18.903382793973%
Interest burden factor: 1.0705025636933145
Tax burden factor: 0.7628259605492687
ROE archetype: Standard Business
DuPont ROE decomposition for CGCL.NS (annual period ending 2024-03-31)
ROE: 7.492727449776007%
Net margin: 13.419064940828187%
Asset turnover: 0.153455679443706
Equity multiplier (leverage): 3.6386033431385743
EBIT margin: 15.223251656815503%
Interest burden factor: 1.1535403758060647
Tax burden factor: 0.7641560004375889
ROE archetype: Standard Business
DuPont ROE decomposition for CGCL.NS (annual period ending 2025-03-31)
ROE: 11.615466119822674%
Net margin: 15.853694898543349%
Asset turnover: 0.16597518064238154
Equity multiplier (leverage): 4.4143117040964786
EBIT margin: 16.622206496618112%
Interest burden factor: 1.2622685508141829
Tax burden factor: 0.7555967144467708
ROE archetype: Standard Business
DuPont ROE decomposition for CGCL.NS (annual period ending 2026-03-31)
ROE: 15.883566880980297%
Net margin: 21.825180477294754%
Asset turnover: 0.15627951116709954
Equity multiplier (leverage): 4.656806026087667
EBIT margin: 24.23225723375072%
Interest burden factor: 1.1931767177531925
Tax burden factor: 0.7548474680871538
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CGCT (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CGCT (quarterly period ending 2025-06-30)
ROE: 0.9947652822794648%
Asset turnover: 0
Equity multiplier (leverage): 1.0539390575939602
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CGCT (quarterly period ending 2025-09-30)
ROE: 1.0368312554578694%
Asset turnover: 0
Equity multiplier (leverage): 1.0508134143224672
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CGCT (quarterly period ending 2025-12-31)
ROE: 0.801080649983809%
Asset turnover: 0
Equity multiplier (leverage): 1.0511163794498333
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CGCT (quarterly period ending 2026-03-31)
ROE: 0.6200338812765829%
Asset turnover: 0
Equity multiplier (leverage): 1.0525831194579693
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CGD.DE (annual period ending 2022-12-31)
ROE: -4.815416980600658%
Net margin: -3.6198090897649062%
Asset turnover: 0.4609077766633751
Equity multiplier (leverage): 2.8862516738909614
EBIT margin: 66.32749772865432%
Interest burden factor: -0.0814133355356282
ROE archetype: Low Return
DuPont ROE decomposition for CGD.DE (annual period ending 2023-12-31)
ROE: 47.06889632985287%
Net margin: 114.23491797096985%
Asset turnover: 0.17573891216122803
Equity multiplier (leverage): 2.344591613350953
EBIT margin: 20.858250967937245%
Interest burden factor: 7.075165426959104
Tax burden factor: 0.7740773980228752
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CGD.DE (annual period ending 2024-12-31)
ROE: -2.139579080243909%
Net margin: -6.287838097931407%
Asset turnover: 0.16794771556070054
Equity multiplier (leverage): 2.0260627467845964
EBIT margin: 11.765151394081814%
Interest burden factor: -0.7108425907880205
ROE archetype: Low Return
DuPont ROE decomposition for CGD.DE (annual period ending 2025-12-31)
ROE: 15.012650790523253%
Net margin: 29.552857842315866%
Asset turnover: 0.24337504612682617
Equity multiplier (leverage): 2.087285475384485
EBIT margin: 36.75546903041485%
Interest burden factor: 1.0196386937506667
Tax burden factor: 0.7885535799018857
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CGEN (quarterly period ending 2025-03-31)
ROE: -12.574420396441829%
Net margin: -314.40455341506134%
Asset turnover: 0.01978465563091742
Equity multiplier (leverage): 2.021485606219794
EBIT margin: -367.55691768826625%
ROE archetype: Low Return
DuPont ROE decomposition for CGEN (quarterly period ending 2025-06-30)
ROE: -14.295021991830115%
Net margin: -584.0891010342085%
Asset turnover: 0.011826003071635467
Equity multiplier (leverage): 2.0695109940155247
EBIT margin: -670.5648369132856%
ROE archetype: Low Return
DuPont ROE decomposition for CGEN (quarterly period ending 2025-09-30)
ROE: -15.025401890971443%
Net margin: -369.0639873083024%
Asset turnover: 0.018736116130489852
Equity multiplier (leverage): 2.172925607500377
EBIT margin: -417.39820200951874%
ROE archetype: Low Return
DuPont ROE decomposition for CGEN (quarterly period ending 2025-12-31)
ROE: 78.49582031975424%
Net margin: 2639.8834266116914%
Asset turnover: 0.01718718399341784
Equity multiplier (leverage): 1.7300436337620853
EBIT margin: -424.26148303314955%
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CGEN (quarterly period ending 2026-03-31)
ROE: -7.768518879832444%
Net margin: -352.4356617647059%
Asset turnover: 0.014437066386808299
Equity multiplier (leverage): 1.5267904165389163
EBIT margin: -414.38419117647055%
ROE archetype: Low Return
DuPont ROE decomposition for CGNR.L (annual period ending 2022-05-31)
ROE: -1.2133995867182314%
Asset turnover: 0
Equity multiplier (leverage): 1.2083587205135558
ROE archetype: Low Return
DuPont ROE decomposition for CGNR.L (annual period ending 2023-05-31)
ROE: -1.6251347946716947%
Asset turnover: 0
Equity multiplier (leverage): 1.1851992287139081
ROE archetype: Low Return
DuPont ROE decomposition for CGNR.L (annual period ending 2024-05-31)
ROE: -2.66313566494766%
Asset turnover: 0
Equity multiplier (leverage): 1.2812126459764284
ROE archetype: Low Return
DuPont ROE decomposition for CGNR.L (annual period ending 2025-05-31)
ROE: -3.1383320953745186%
Asset turnover: 0
Equity multiplier (leverage): 1.426313463541527
ROE archetype: Low Return
DuPont ROE decomposition for CGPOWER.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.8026952221554193
ROE archetype: Standard Business
DuPont ROE decomposition for CGPOWER.NS (quarterly period ending 2024-12-31)
Net margin: 9.561231953189594%
EBIT margin: 12.030146918526999%
Interest burden factor: 1.1064631245043615
Tax burden factor: 0.7183001851520038
ROE archetype: Standard Business
DuPont ROE decomposition for CGPOWER.NS (quarterly period ending 2025-03-31)
ROE: 6.7925986284032955%
Net margin: 9.963055395111105%
Asset turnover: 0.3711398166661498
Equity multiplier (leverage): 1.8369860536998188
EBIT margin: 11.441929402020511%
Interest burden factor: 1.2180207638822744
Tax burden factor: 0.7148889583984986
ROE archetype: Standard Business
DuPont ROE decomposition for CGPOWER.NS (quarterly period ending 2025-06-30)
Net margin: 9.354597731102656%
EBIT margin: 11.734334010875418%
Interest burden factor: 1.0771645149828262
Tax burden factor: 0.7400901643850679
ROE archetype: Standard Business
DuPont ROE decomposition for CGPOWER.NS (quarterly period ending 2025-12-31)
Net margin: 8.97003479931346%
EBIT margin: 10.916906797675846%
Interest burden factor: 1.1076590220683686
Tax burden factor: 0.7418027450061203
ROE archetype: Standard Business
DuPont ROE decomposition for CGPOWER.NS (quarterly period ending 2026-03-31)
ROE: 4.458146555667368%
Net margin: 10.61927618427781%
Asset turnover: 0.2716976604110799
Equity multiplier (leverage): 1.54516024761382
EBIT margin: 12.119380781925527%
Interest burden factor: 1.175704833141542
Tax burden factor: 0.7452743622683061
ROE archetype: Low Return
DuPont ROE decomposition for CGPOWER.NS (quarterly period ending 2026-06-30)
Net margin: 9.540631734236364%
EBIT margin: 10.448944010777826%
Interest burden factor: 1.2335696158221758
Tax burden factor: 0.7401863412788497
ROE archetype: Standard Business
DuPont ROE decomposition for CHCT (annual period ending 2022-12-31)
ROE: 4.432040965029166%
Net margin: 22.542204568023834%
Asset turnover: 0.11145163590723678
Equity multiplier (leverage): 1.764090786491524
EBIT margin: 34.67173087357569%
Interest burden factor: 0.6513715416186848
Tax burden factor: 0.9981414324569357
ROE archetype: Low Return
DuPont ROE decomposition for CHCT (annual period ending 2023-12-31)
ROE: 1.527418891759977%
Net margin: 6.835925384376799%
Asset turnover: 0.12388045692342399
Equity multiplier (leverage): 1.8036740027918856
EBIT margin: 22.243785723780405%
Interest burden factor: 0.31950918290107966
Tax burden factor: 0.9618453865336658
ROE archetype: Low Return
DuPont ROE decomposition for CHCT (annual period ending 2024-12-31)
ROE: -0.6431323233129906%
Net margin: -2.7473096920180335%
Asset turnover: 0.11949173750951379
Equity multiplier (leverage): 1.9590920532418943
EBIT margin: 17.373430293817904%
Interest burden factor: -0.15813282958838734
ROE archetype: Low Return
DuPont ROE decomposition for CHCT (annual period ending 2025-12-31)
ROE: 1.1270754358525745%
Net margin: 4.209744626428483%
Asset turnover: 0.12221426698666882
Equity multiplier (leverage): 2.190661753660455
EBIT margin: 16.721811955938776%
Interest burden factor: 0.25288660811210895
Tax burden factor: 0.9955121951219512
ROE archetype: Low Return
DuPont ROE decomposition for CHI (annual period ending 2022-10-31)
ROE: -39.237831179408005%
Asset turnover: -0.23980624251414037
Equity multiplier (leverage): 1.6317208039705118
ROE archetype: Low Return
DuPont ROE decomposition for CHI (annual period ending 2023-10-31)
ROE: -1.3724615447889494%
Asset turnover: -0.007719531626847519
Equity multiplier (leverage): 1.6504088477915315
ROE archetype: Low Return
DuPont ROE decomposition for CHI (annual period ending 2024-10-31)
ROE: 22.909581486786127%
Net margin: 99.58643923627527%
Asset turnover: 0.1407802287206021
Equity multiplier (leverage): 1.634087413517014
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHI (annual period ending 2025-10-31)
ROE: 20.986735663720548%
Net margin: 99.61731358548866%
Asset turnover: 0.13614795183544193
Equity multiplier (leverage): 1.5473870370474383
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHSN (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.2672902463256523
ROE archetype: Standard Business
DuPont ROE decomposition for CHSN (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.1714629542199373
ROE archetype: Standard Business
DuPont ROE decomposition for CHT (quarterly period ending 2025-03-31)
ROE: 2.497287957707287%
Net margin: 18.39451348388296%
Asset turnover: 0.10317468429322743
Equity multiplier (leverage): 1.3158523748620001
EBIT margin: 22.590649323207913%
Interest burden factor: 1.0141628894808583
Tax burden factor: 0.802882287447424
ROE archetype: Low Return
DuPont ROE decomposition for CHT (quarterly period ending 2025-06-30)
ROE: 2.875971831669173%
Net margin: 18.803801959636274%
Asset turnover: 0.11108719729766016
Equity multiplier (leverage): 1.3768129738651702
EBIT margin: 22.235326931717715%
Interest burden factor: 1.04708037360819
Tax burden factor: 0.8076480148103726
ROE archetype: Low Return
DuPont ROE decomposition for CHT (quarterly period ending 2025-09-30)
ROE: 2.5014480515378192%
Net margin: 17.10842732204411%
Asset turnover: 0.10635360105152208
Equity multiplier (leverage): 1.3747673191652243
EBIT margin: 21.002929257626274%
Interest burden factor: 1.0132170380781493
Tax burden factor: 0.8039475858931836
ROE archetype: Low Return
DuPont ROE decomposition for CHT (quarterly period ending 2025-12-31)
ROE: 2.4623180411172023%
Net margin: 15.05682263514672%
Asset turnover: 0.12303055162384985
Equity multiplier (leverage): 1.329222981349154
EBIT margin: 17.606531495453552%
Interest burden factor: 1.0589823658834645
Tax burden factor: 0.8075525601786191
ROE archetype: Low Return
DuPont ROE decomposition for CHT (quarterly period ending 2026-03-31)
ROE: 2.586909175169347%
Net margin: 17.77737027592717%
Asset turnover: 0.10876628200602376
Equity multiplier (leverage): 1.3378868336449474
EBIT margin: 21.958508528032034%
Interest burden factor: 1.0059626338255487
Tax burden factor: 0.804790480038086
ROE archetype: Low Return
DuPont ROE decomposition for CIG.C (annual period ending 2022-12-31)
ROE: 18.793609988982745%
Net margin: 9.369278652508239%
Asset turnover: 0.8141454416724115
Equity multiplier (leverage): 2.463780756518546
EBIT margin: 8.046503112413037%
Interest burden factor: 1.1717861205915814
Tax burden factor: 0.9936893203883496
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIG.C (annual period ending 2023-12-31)
ROE: 25.82281727206457%
Net margin: 12.674725274725276%
Asset turnover: 0.8724826669700358
Equity multiplier (leverage): 2.3351149238912043
EBIT margin: 13.654945054945056%
Interest burden factor: 1.1026879124416549
Tax burden factor: 0.8417749233688512
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIG.C (annual period ending 2024-12-31)
ROE: 24.214559123642537%
Net margin: 14.374558303886928%
Asset turnover: 0.7630413772953049
Equity multiplier (leverage): 2.207669046547198
EBIT margin: 16.03836446239273%
Interest burden factor: 1.178144277980612
Tax burden factor: 0.7607394742466339
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIG.C (annual period ending 2025-12-31)
ROE: 18.535236228631256%
Net margin: 9.396758415651673%
Asset turnover: 0.8689904886741995
Equity multiplier (leverage): 2.269891198202152
EBIT margin: 12.137719382372685%
Interest burden factor: 0.8960176991150443
Tax burden factor: 0.864021164021164
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CIGI.TO (annual period ending 2022-12-31)
ROE: 12.370221532670344%
Net margin: 4.36247487659455%
Asset turnover: 0.8747218858819534
Equity multiplier (leverage): 3.2417128722944275
EBIT margin: 9.787538342414722%
Interest burden factor: 0.6633934667357048
Tax burden factor: 0.6718746762261961
ROE archetype: Standard Business
DuPont ROE decomposition for CIGI.TO (annual period ending 2023-12-31)
ROE: 8.390362970324805%
Net margin: 3.337630771409742%
Asset turnover: 0.8312546078559578
Equity multiplier (leverage): 3.024185261418753
EBIT margin: 8.080775227380148%
Interest burden factor: 0.6073911045265235
Tax burden factor: 0.6800124073560582
ROE archetype: Standard Business
DuPont ROE decomposition for CIGI.TO (annual period ending 2024-12-31)
ROE: 10.38972200863457%
Net margin: 4.913621334111983%
Asset turnover: 0.8010281526687495
Equity multiplier (leverage): 2.639699334359285
EBIT margin: 7.49498550816006%
Interest burden factor: 0.8608311889543732
Tax burden factor: 0.761575376149502
ROE archetype: Standard Business
DuPont ROE decomposition for CIGI.TO (annual period ending 2025-12-31)
ROE: 8.64711589119847%
Net margin: 4.039840517035108%
Asset turnover: 0.8799828728506834
Equity multiplier (leverage): 2.432387928651067
EBIT margin: 7.223688854938651%
Interest burden factor: 0.758872401787182
Tax burden factor: 0.7369472969114591
ROE archetype: Standard Business
DuPont ROE decomposition for CINF (quarterly period ending 2025-03-31)
ROE: -0.6560723137483598%
Net margin: -3.507404520654715%
Asset turnover: 0.06883785813928534
Equity multiplier (leverage): 2.717305729698207
ROE archetype: Low Return
DuPont ROE decomposition for CINF (quarterly period ending 2025-06-30)
ROE: 4.8895392412291665%
Net margin: 21.089901477832512%
Asset turnover: 0.08534118079823431
Equity multiplier (leverage): 2.716656554480888
Tax burden factor: 0.8011695906432749
ROE archetype: Low Return
DuPont ROE decomposition for CINF (quarterly period ending 2025-09-30)
ROE: 7.553775204497256%
Net margin: 30.112721417069245%
Asset turnover: 0.09384326713596695
Equity multiplier (leverage): 2.673073686336554
Tax burden factor: 0.7940552016985138
ROE archetype: Standard Business
DuPont ROE decomposition for CINF (quarterly period ending 2025-12-31)
ROE: 4.3171440431714405%
Net margin: 21.869945001617598%
Asset turnover: 0.07578859615785409
Equity multiplier (leverage): 2.6046236868154677
Tax burden factor: 0.8047619047619048
ROE archetype: Low Return
DuPont ROE decomposition for CINF (quarterly period ending 2026-03-31)
ROE: 1.732806324110672%
Net margin: 9.570380719524973%
Asset turnover: 0.0696483524503424
Equity multiplier (leverage): 2.5996205533596837
Tax burden factor: 0.8404907975460123
ROE archetype: Low Return
DuPont ROE decomposition for CISO (quarterly period ending 2025-03-31)
ROE: -77.07870271865707%
Net margin: -75.10977585202117%
Asset turnover: 0.2574589092558176
Equity multiplier (leverage): 3.9859331042293964
EBIT margin: -23.871378583649268%
ROE archetype: Low Return
DuPont ROE decomposition for CISO (quarterly period ending 2025-06-30)
ROE: -41.42470882207056%
Net margin: -44.83327616071707%
Asset turnover: 0.25046739815555263
Equity multiplier (leverage): 3.6889926017106514
EBIT margin: -34.696608534305135%
ROE archetype: Low Return
DuPont ROE decomposition for CISO (quarterly period ending 2025-09-30)
ROE: 21.196575473462932%
Net margin: 39.19076393288679%
Asset turnover: 0.25402389554283217
Equity multiplier (leverage): 2.1291555990054696
EBIT margin: -40.762756743556515%
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CISO (quarterly period ending 2025-12-31)
ROE: -14.227805350372302%
Net margin: -35.36582778304326%
Asset turnover: 0.25015838704657956
Equity multiplier (leverage): 1.6081961541533576
EBIT margin: -33.692006321978354%
ROE archetype: Low Return
DuPont ROE decomposition for CISO (quarterly period ending 2026-03-31)
ROE: -11.089588235770357%
Net margin: -25.5437778572663%
Asset turnover: 0.2548462191994797
Equity multiplier (leverage): 1.70353906515871
EBIT margin: -23.21502493840756%
ROE archetype: Low Return
DuPont ROE decomposition for CKG.V (annual period ending 2022-12-31)
ROE: -6.970024339767536%
Asset turnover: 0
Equity multiplier (leverage): 1.0713858048393186
ROE archetype: Low Return
DuPont ROE decomposition for CKG.V (annual period ending 2023-12-31)
ROE: -3.7694463291784808%
Asset turnover: 0
Equity multiplier (leverage): 1.0782613656312057
ROE archetype: Low Return
DuPont ROE decomposition for CKG.V (annual period ending 2024-12-31)
ROE: -1.626439343367237%
Asset turnover: 0
Equity multiplier (leverage): 1.0854299208534435
ROE archetype: Low Return
DuPont ROE decomposition for CKG.V (annual period ending 2025-12-31)
ROE: -2.9743129168573064%
Asset turnover: 0
Equity multiplier (leverage): 1.085095331993802
ROE archetype: Low Return
DuPont ROE decomposition for CLBS.L (annual period ending 2022-03-31)
ROE: 5.315979305104375%
Net margin: 6.9299644367112405%
Asset turnover: 0.4539026833811216
Equity multiplier (leverage): 1.6900109770358906
EBIT margin: 6.966760709599054%
Interest burden factor: 1.0346244135964897
Tax burden factor: 0.9614293811037699
ROE archetype: Standard Business
DuPont ROE decomposition for CLBS.L (annual period ending 2023-03-31)
ROE: 6.679517769942373%
Net margin: 9.906874427647937%
Asset turnover: 0.4245915226555252
Equity multiplier (leverage): 1.5879511293990427
EBIT margin: 9.541859716570022%
Interest burden factor: 1.1726336423544956
Tax burden factor: 0.8854035953031444
ROE archetype: Standard Business
DuPont ROE decomposition for CLBS.L (annual period ending 2024-03-31)
ROE: 14.281870618252087%
Net margin: 12.273149733405079%
Asset turnover: 0.6693238230287301
Equity multiplier (leverage): 1.73857239149083
EBIT margin: 13.860490143325343%
Interest burden factor: 1.2290453502735135
Tax burden factor: 0.72045944005743
ROE archetype: Standard Business
DuPont ROE decomposition for CLBS.L (annual period ending 2025-03-31)
ROE: 16.205073609108396%
Net margin: 16.530058177117%
Asset turnover: 0.5994708736216334
Equity multiplier (leverage): 1.6353418053916482
EBIT margin: 17.50743374272786%
Interest burden factor: 1.0841825431989367
Tax burden factor: 0.8708622803432775
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CLBS.L (annual period ending 2026-03-31)
ROE: -1.1792233994086707%
Net margin: -2.0219575261752363%
Asset turnover: 0.4375305068867133
Equity multiplier (leverage): 1.3329557125827172
EBIT margin: -5.235047263787037%
ROE archetype: Low Return
DuPont ROE decomposition for CLCO.V (annual period ending 2023-12-31)
ROE: -6.660737226998716%
Asset turnover: 0
Equity multiplier (leverage): 1
ROE archetype: Low Return
DuPont ROE decomposition for CLCO.V (annual period ending 2024-12-31)
ROE: -27.23411511310968%
Asset turnover: 0
Equity multiplier (leverage): 1.0856543144878164
ROE archetype: Low Return
DuPont ROE decomposition for CLCO.V (annual period ending 2025-12-31)
ROE: -14.800191562147521%
Asset turnover: 0
Equity multiplier (leverage): 1.1364973697141005
ROE archetype: Low Return
DuPont ROE decomposition for CLEANMAX.NS (quarterly period ending 2025-03-31)
ROE: 0.6867257056896072%
Net margin: 4.982499671727347%
Asset turnover: 0.03326286501206054
Equity multiplier (leverage): 4.14358614479091
EBIT margin: 39.80656816977809%
Interest burden factor: 0.1490376959301135
Tax burden factor: 0.8398397252432741
ROE archetype: Low Return
DuPont ROE decomposition for CLEANMAX.NS (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 4.569154857056479
ROE archetype: Standard Business
DuPont ROE decomposition for CLEANMAX.NS (quarterly period ending 2026-03-31)
ROE: 1.212741069906147%
Net margin: 9.993616491811437%
Asset turnover: 0.02696903685817199
Equity multiplier (leverage): 4.499662798640641
EBIT margin: 30.824410246792915%
Interest burden factor: 0.44024734114123254
Tax burden factor: 0.7364294731247093
ROE archetype: Low Return
DuPont ROE decomposition for CLEO.MC (annual period ending 2022-12-31)
ROE: 29.70420723865515%
Net margin: 31.876971608832804%
Asset turnover: 0.40328864717014135
Equity multiplier (leverage): 2.3106007716332906
EBIT margin: 1.3564668769716088%
Interest burden factor: 16.00290697674419
Tax burden factor: 1.4684831970935512
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CLEO.MC (annual period ending 2023-12-31)
ROE: 3.7103963850113435%
Net margin: 3.4663178548070634%
Asset turnover: 0.47182878113510074
Equity multiplier (leverage): 2.268649976716438
EBIT margin: 2.357922274620495%
Interest burden factor: 2.014598540145985
Tax burden factor: 0.7297101449275362
ROE archetype: Low Return
DuPont ROE decomposition for CLEO.MC (annual period ending 2024-12-31)
ROE: 2.1234543332941356%
Net margin: 1.9884378374944414%
Asset turnover: 0.48225487317614923
Equity multiplier (leverage): 2.2143908693725067
EBIT margin: 4.164284352963598%
Interest burden factor: 0.6384439359267735
Tax burden factor: 0.7479091995221028
ROE archetype: Low Return
DuPont ROE decomposition for CLEO.MC (annual period ending 2025-12-31)
ROE: 4.4819370210573775%
Net margin: 3.4934864827006584%
Asset turnover: 0.4832043848705327
Equity multiplier (leverage): 2.655069023147989
EBIT margin: 4.4684129429892145%
Interest burden factor: 1.238244514106583
Tax burden factor: 0.6313924050632911
ROE archetype: Low Return
DuPont ROE decomposition for CLF (annual period ending 2022-12-31)
ROE: 17.1101715991047%
Net margin: 5.985471312366784%
Asset turnover: 1.2257531324980004
Equity multiplier (leverage): 2.332131310619249
EBIT margin: 8.578015572665187%
Interest burden factor: 0.9107505070993914
Tax burden factor: 0.7661469933184856
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CLF (annual period ending 2023-12-31)
ROE: 5.394704281118535%
Net margin: 1.9821785779232586%
Asset turnover: 1.2121679709026782
Equity multiplier (leverage): 2.2452363276416727
EBIT margin: 3.618839789052555%
Interest burden factor: 0.7273869346733668
Tax burden factor: 0.7530224525043178
ROE archetype: Standard Business
DuPont ROE decomposition for CLF (annual period ending 2024-12-31)
ROE: -9.526986456734939%
Net margin: -3.7216575449569973%
Asset turnover: 0.9970377299657001
Equity multiplier (leverage): 2.5674828207352056
EBIT margin: -2.6635392233515764%
ROE archetype: Low Return
DuPont ROE decomposition for CLF (annual period ending 2025-12-31)
ROE: -21.652767247915087%
Net margin: -7.673293927995702%
Asset turnover: 0.9087135916404209
Equity multiplier (leverage): 3.1053070507960574
EBIT margin: -7.807630306286943%
ROE archetype: Low Return
DuPont ROE decomposition for CLIQ.DE (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.3801561071654596
ROE archetype: Standard Business
DuPont ROE decomposition for CLIQ.DE (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.3272154233697384
ROE archetype: Standard Business
DuPont ROE decomposition for CLIQ.DE (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.2521106085556952
ROE archetype: Standard Business
DuPont ROE decomposition for CLNE (annual period ending 2022-12-31)
ROE: -8.073586438497205%
Net margin: -13.978589312744546%
Asset turnover: 0.388193544274209
Equity multiplier (leverage): 1.4878352539139017
EBIT margin: -12.306385125808019%
ROE archetype: Low Return
DuPont ROE decomposition for CLNE (annual period ending 2023-12-31)
ROE: -13.619297004074962%
Net margin: -23.402303608767543%
Asset turnover: 0.36310212378005946
Equity multiplier (leverage): 1.6027555611524873
EBIT margin: -17.96974778847443%
ROE archetype: Low Return
DuPont ROE decomposition for CLNE (annual period ending 2024-12-31)
ROE: -11.432873330039403%
Net margin: -19.975232347035696%
Asset turnover: 0.3322469220232576
Equity multiplier (leverage): 1.7226719644806072
EBIT margin: -6.793310329073137%
ROE archetype: Low Return
DuPont ROE decomposition for CLNE (annual period ending 2025-12-31)
ROE: -34.567078572440565%
Net margin: -52.26147686267309%
Asset turnover: 0.36932253096682743
Equity multiplier (leverage): 1.7909159129937926
EBIT margin: -22.48789524354276%
ROE archetype: Low Return
DuPont ROE decomposition for CLOV (quarterly period ending 2025-03-31)
ROE: -0.3790820501376181%
Net margin: -0.27556015062801326%
Asset turnover: 0.7920464882811362
Equity multiplier (leverage): 1.7368652830469389
EBIT margin: -0.27556015062801326%
ROE archetype: Low Return
DuPont ROE decomposition for CLOV (quarterly period ending 2025-06-30)
ROE: -3.1100147885936726%
Net margin: -2.214731376408023%
Asset turnover: 0.8244038166779436
Equity multiplier (leverage): 1.703340222916734
EBIT margin: -2.2107533185377495%
ROE archetype: Low Return
DuPont ROE decomposition for CLOV (quarterly period ending 2025-09-30)
ROE: -7.116219123616466%
Net margin: -4.908285512936676%
Asset turnover: 0.8754272257602812
Equity multiplier (leverage): 1.6561491495538678
EBIT margin: -4.908285512936676%
ROE archetype: Low Return
DuPont ROE decomposition for CLOV (quarterly period ending 2025-12-31)
ROE: -15.18388759243638%
Net margin: -10.112629099028721%
Asset turnover: 0.8862002235002316
Equity multiplier (leverage): 1.6942872624054086
EBIT margin: -10.112424057887214%
ROE archetype: Low Return
DuPont ROE decomposition for CLOV (quarterly period ending 2026-03-31)
ROE: 8.434727600944255%
Net margin: 3.648478554810602%
Asset turnover: 1.2095994394299363
Equity multiplier (leverage): 1.911250829308935
EBIT margin: 3.648478554810602%
Interest burden factor: 1
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CLS (quarterly period ending 2025-03-31)
ROE: 5.536998972250772%
Net margin: 3.254549573359511%
Asset turnover: 0.45392380332139365
Equity multiplier (leverage): 3.7480087358684484
EBIT margin: 5.010194064788945%
Interest burden factor: 0.8568198944988696
Tax burden factor: 0.7581354441512753
ROE archetype: Standard Business
DuPont ROE decomposition for CLS (quarterly period ending 2025-06-30)
ROE: 12.987094040325717%
Net margin: 7.292458699108316%
Asset turnover: 0.4891143976216451
Equity multiplier (leverage): 3.6410576908384673
EBIT margin: 9.919126287412732%
Interest burden factor: 0.8965156794425087
Tax burden factor: 0.8200544111931597
ROE archetype: Standard Business
DuPont ROE decomposition for CLS (quarterly period ending 2025-09-30)
ROE: 14.049767331340353%
Net margin: 8.384470882905449%
Asset turnover: 0.4937046112478696
Equity multiplier (leverage): 3.3941129266812737
EBIT margin: 10.32874139010645%
Interest burden factor: 0.9424067899363444
Tax burden factor: 0.8613702155033773
ROE archetype: Standard Business
DuPont ROE decomposition for CLS (quarterly period ending 2025-12-31)
ROE: 12.690621704794275%
Net margin: 7.318941694711209%
Asset turnover: 0.5326002700160001
Equity multiplier (leverage): 3.2556164085736827
EBIT margin: 8.77725792771348%
Interest burden factor: 0.9392144638403991
Tax burden factor: 0.8878194490540989
ROE archetype: Standard Business
DuPont ROE decomposition for CLS (quarterly period ending 2026-03-31)
ROE: 9.767982252794244%
Net margin: 5.245861131702496%
Asset turnover: 0.5195655279589104
Equity multiplier (leverage): 3.5838328275281177
EBIT margin: 6.6147763775636275%
Interest burden factor: 0.9574150168098617
Tax burden factor: 0.8283261802575108
ROE archetype: Standard Business
DuPont ROE decomposition for CLVT (quarterly period ending 2025-03-31)
ROE: -2.0667979550834477%
Net margin: -17.50042108809163%
Asset turnover: 0.05165887911456838
Equity multiplier (leverage): 2.2861490720295996
EBIT margin: 4.143506821627084%
Interest burden factor: -3.4593495934959346
ROE archetype: Low Return
DuPont ROE decomposition for CLVT (quarterly period ending 2025-06-30)
ROE: -1.475401983170198%
Net margin: -11.586739620212425%
Asset turnover: 0.055688796464384446
Equity multiplier (leverage): 2.2865530575204516
EBIT margin: 7.869327325394271%
Interest burden factor: -1.2208588957055213
ROE archetype: Low Return
DuPont ROE decomposition for CLVT (quarterly period ending 2025-09-30)
ROE: -0.5679131672065677%
Net margin: -4.541807093564437%
Asset turnover: 0.05464530044625619
Equity multiplier (leverage): 2.28823400694504
EBIT margin: 6.515808056491734%
Interest burden factor: -0.603448275862069
ROE archetype: Low Return
DuPont ROE decomposition for CLVT (quarterly period ending 2025-12-31)
ROE: 0.06361127355925596%
Net margin: 0.5024311183144247%
Asset turnover: 0.0553437682199399
Equity multiplier (leverage): 2.2876460750818226
EBIT margin: 9.40032414910859%
Interest burden factor: -0.4241379310344828
ROE archetype: Low Return
DuPont ROE decomposition for CLVT (quarterly period ending 2026-03-31)
ROE: -0.8235520151665569%
Net margin: -6.865926558497011%
Asset turnover: 0.05252140186212353
Equity multiplier (leverage): 2.283786866465974
EBIT margin: 5.0555081127241674%
Interest burden factor: -0.9729729729729729
ROE archetype: Low Return
DuPont ROE decomposition for CLW (annual period ending 2022-12-31)
ROE: 8.041958041958042%
Net margin: 3.8493723849372383%
Asset turnover: 0.701496918109774
Equity multiplier (leverage): 2.9781468531468533
EBIT margin: 8.443514644351465%
Interest burden factor: 0.8116947472745293
Tax burden factor: 0.5616605616605617
ROE archetype: Standard Business
DuPont ROE decomposition for CLW (annual period ending 2023-12-31)
ROE: 17.361167083098252%
Net margin: 9.480633802816902%
Asset turnover: 0.6731253518205789
Equity multiplier (leverage): 2.7204803739824293
EBIT margin: 7.051056338028169%
Interest burden factor: 0.818976279650437
Tax burden factor: 1.641768292682927
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CLW (annual period ending 2024-12-31)
ROE: 25.774684873949578%
Net margin: 14.187626481642093%
Asset turnover: 0.8257833482542525
Equity multiplier (leverage): 2.1999737394957983
EBIT margin: -2.963284186180977%
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CLW (annual period ending 2025-12-31)
ROE: -2.2145493511132277%
Net margin: -1.1958338691011958%
Asset turnover: 0.9520428462127009
Equity multiplier (leverage): 1.945172044290987
EBIT margin: 0.7843641507007844%
Interest burden factor: -4.926229508196721
ROE archetype: Low Return
DuPont ROE decomposition for CLWT (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.2404456691026717
ROE archetype: Standard Business
DuPont ROE decomposition for CLWT (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.2250508252019856
ROE archetype: Standard Business
DuPont ROE decomposition for CLWT (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.2482314927318487
ROE archetype: Standard Business
DuPont ROE decomposition for CLX.L (annual period ending 2022-03-31)
ROE: 20.798973795125526%
Net margin: 20.593304907919805%
Asset turnover: 0.7078503772676191
Equity multiplier (leverage): 1.4268370899761773
EBIT margin: 27.184069672502947%
Interest burden factor: 0.9966627732354414
Tax burden factor: 0.7600870584295998
ROE archetype: High-Margin Compounder